Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001906324-24-000043
Filing Date
2024-08-01
Accepted
2024-07-31 18:33:58
Documents
124
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A qdel-20231231.htm   iXBRL 10-K/A 1746494
2 EX-23.1 ex231consent12312023-10xka.htm EX-23.1 3428
3 EX-31.1 ex3111231202310-ka.htm EX-31.1 9687
4 EX-31.2 ex3121231202310-ka.htm EX-31.2 9795
5 EX-32.1 ex3211231202310-ka.htm EX-32.1 5590
  Complete submission text file 0001906324-24-000043.txt   13670891

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT qdel-20231231.xsd EX-101.SCH 94164
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT qdel-20231231_cal.xml EX-101.CAL 154664
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT qdel-20231231_def.xml EX-101.DEF 548425
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT qdel-20231231_lab.xml EX-101.LAB 1143614
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT qdel-20231231_pre.xml EX-101.PRE 859811
127 EXTRACTED XBRL INSTANCE DOCUMENT qdel-20231231_htm.xml XML 2508252
Mailing Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121
Business Address 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 (858) 552-1100
QuidelOrtho Corp (Filer) CIK: 0001906324 (see all company filings)

EIN.: 874496285 | Fiscal Year End: 0101
Type: 10-K/A | Act: 34 | File No.: 001-41409 | Film No.: 241163434
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)